Natalia Buza MD

Assistant Professor of Pathology

diagnostic and prognostic markers in endometrial, ovarian and breast cancer

Buza N, Zekry N, Charpin C, Tavassoli FA. Myoepithelial carcinoma of the breast: a clinicopathological and immunohistochemical study of 15 diagnostically challenging cases. Virchows Arch. 2010 Sep;457(3):337-45. Epub 2010 Jul 24.
Richter CE, Hui P, Buza N, Silasi DA, Azodi M, Santin AD, Schwartz PE, Rutherford TJ. HER-2/NEU overexpression in vulvar Paget disease: the Yale experience. J Clin Pathol. 2010 Jun;63(6):544-7. Epub 2010 Apr 23.
Buza N, Cohen P, Hui P, Parkash V. Inverse p16 and p63 Expression in Small Cell Carcinoma and High Grade Urothelial Cell Carcinoma of the Urinary Bladder. Int J Sug Pathol, 2010, 18(2):94-102.
Cocco E, Hu Z, Richter CE, Bellone S, Casagrande F, Bellone M, Todeschini P, Krikun G, Silasi DA, Azodi M, Schwartz PE, Rutherford TJ, Buza N, Pecorelli S, Lockwood CJ, Santin AD. hI-con1, a factor VII-IgGFc chimeric protein targeting tissue factor for immunotherapy of uterine serous papillary carcinoma. Br J Cancer. 2010 Sep 7;103(6):812-9. Epub 2010 Aug 10.
Buza N, Tavassoli FA. Comparative analysis of p16 and p53 expression in uterine malignant mixed mullerian tumors. Int J Gynecol Pathol. 2009;28:514-21.